3.70Open3.70Pre Close0 Volume11 Open Interest20.00Strike Price0.00Turnover0.00%IV7.28%PremiumOct 18, 2024Expiry Date2.42Intrinsic Value100Multiplier-2DDays to Expiry1.28Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma5.67Leverage Ratio--Theta--Rho--Eff Leverage--Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet